13423-22-8 Usage
General Description
2-Azetidinone, 3,3,4,4-tetramethyl- is a chemical compound with the molecular formula C8H15NO. Also known as N-tert-butyl-2-azetidinone, it is a white to off-white crystalline powder that is soluble in organic solvents. 2-Azetidinone, 3,3,4,4-tetramethyl- is primarily used as a building block and intermediate in the synthesis of various pharmaceuticals and agrochemicals. It is also utilized in the production of polymers and as a chiral auxiliary in organic synthesis. Additionally, 2-Azetidinone, 3,3,4,4-tetramethyl- has applications as an intermediate in the synthesis of various compounds for research and development purposes. While it has been identified as a potential skin and eye irritant, its specific hazards and safety considerations should be determined based on the specific application and handling conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 13423-22-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,3,4,2 and 3 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 13423-22:
(7*1)+(6*3)+(5*4)+(4*2)+(3*3)+(2*2)+(1*2)=68
68 % 10 = 8
So 13423-22-8 is a valid CAS Registry Number.
13423-22-8Relevant articles and documents
A New Approach Using Aromatic-Solvent-Induced Shifts in NMR Spectroscopy to Analyze β-Lactams with Various Substitution Patterns
Chavelas-Hernández, Leticia,Dominguez-Mendoza, Blanca E.,Escalante, Jaime,Hernández-Vázquez, Luis G.,Valdéz-Camacho, Jonathan R.,Vasquez-Ríos, María G.
, p. 158 - 164 (2020)
The chemical shifts of protons depend not only on the properties of the solute molecule but also on the medium in which the solute resides. A series of β-lactams with various substitution patterns were synthesized to study aromatic-solvent-induced shifts
PARTIALLY SATURATED NITROGEN-CONTAINING HETEROCYCLIC COMPOUND
-
Paragraph 0266; 0267, (2015/06/17)
There are provided compounds having a superior PHD2 inhibitory effect that are represented by general formula (I'): (in the above-mentioned general formula (I'), W, Y, R2, R3, R4, and Y4 are as described hereinabove), or pharmaceutically acceptable salts thereof.